P02.148. Assessing interactions between herbal medicines and drugs: updated review

by Girard L, Necyk C, Jassar S, Filipelli A, Gardiner P, Boon H, Vohra S
Published 2012-06-01

P05.32. A tool for rapid identification of potential herbal medicine-drug interactions 2011 update: a review

by Girard L, Kutt A, Necyk C, Jasser S, Law B, Filipelli A, Gardiner P, Boon H, Vohra S
Published 2012-06-01

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

by Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO
Published 2016-02-01

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

by Kaseb AO, Morris JS, Iwasaki M, Al-Shamsi HO, Raghav KP, Girard L, Cheung S, Nguyen V, Elsayes KM, Xiao L, Abdel-Wahab R, Shalaby AS, Hassan M, Hassabo HM, Wolff RA, Yao JC
Published 2016-02-01